WELCOME TO The chemical REPORT
Alpha Chi Sigma Fraternity
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Polytek | September 07, 2021
Polytek Development Corp, a manufacturer of specialty polymers for coating, mold making, and casting applications, announced today the acquisition of Specialty Resin & Chemical. Polytek is a portfolio company of Arsenal Capital Partners.
Founded in 2007 and located in Dowagiac, MI, Specialty Resin & Chemical is a supplier of user-friendly mold making, casting, and coating products, including bar top epoxy resin and polyurethane resin. They fit in well alongside Polytek'...
Oberon Fuels | July 01, 2022
Oberon Fuels a maker of products that reduce greenhouse gas emissions of major energy sectors, has joined both the World Biogas Association and Liquid Gas Europe as Oberon continues to build upon its work in Europe and around the world.
Oberon has developed a straightforward ‘here-now’ way to slash the CO2 emissions of the global Liquefied Petroleum Gas industry through the production of renewable dimethyl ether. Because rDME can be stored, transported and dispensed us...
AMP Robotics Corp | March 08, 2022
AMP Robotics Corp a pioneer in AI robotics, and infrastructure for the waste and recycling industry, has extended its partnership with Evergreen, one of North America’s three largest producers of food-grade recycled polyethylene terephthalate (rPET). Evergreen, which has grown through acquisitions to four locations across North America from its original facility in Clyde, Ohio, now has 15 of AMP’s robotic sorting systems guided by artificial intelligence installed or planned across t...
Celanese | August 25, 2022
Celanese Corporation a global chemical and specialty materials company, announced receipt of a grant from the Bill & Melinda Gates Foundation to produce and characterize a working prototype for a refillable contraceptive implant. The research and development will be conducted within the Celanese Pharmaceutical Development and Feasibility Lab and the project is expected to produce a functional prototype that meets all established project parameters within an 18-month timeframe.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE